The purpose of Novozymes' investor relations The purpose of this department is to ensure that relevant, accurate and timely information is made available to the share market as a basis for regular trading and fair pricing of the Novozymes share.
It is also to ensure that Novozymes is perceived as a visible, accessible, reliable and professional company by the stock market, and that the company's investor relations department is regarded among the best relative to comparable companies.
This should achieved while observing the rules and legislation for listed companies on the OMX Nordic Exchange Copenhagen and by complying with Novozymes'
policy for communication.
Also, Novozymes' investor relations department strives to- maintain a high and uniform level of information from Novozymes and ensure that information is channelled back from the stock market to Novozymes' Executive Management and Board of Directors.
- continuously ensure awareness of and confidence in Novozymes'
vision, strategy,
policies and decisions among the players in the stock market, and generally support Novozymes' brand and values.
- ensure broad coverage by both domestic and foreign equity analysts.
- ensure a diverse shareholder base in terms of both investment horizon and geographical location.
- be active, proactive and known by Danish and foreign institutional investors, e.g. by:
-
Having at least 250 individual investor meetings a year, including during roadshows after each quarterly group financial statement
-
Making presentations for investors and equity analysts on relevant topics and contributing to industry conferences
-
Having capital markets days and arranging investor visits to Novozymes' locations around the world
-
Ensuring that "Investor" on the novozymes.com is kept fully up-to-date
Finally, Novozymes observes the following principles while working with investor relations:
-
Investor and analyst meetings are not held during the 28 days leading up to the publication of a quarterly group financial statement
-
Only members of the Executive Management and Investor Relations may comment to investors and analysts unless otherwise agreed
-
All teleconferences and quarterly investor presentations are made available to all via "Investor" at novozymes.com
(Last updated: 12/02/2008)